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therefore, makes segmentation of different heart structures 
feasible in the clinic.  
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Purpose/Objective: There is an increasing tendency to 
consider axillary radiotherapy (AR) in preference to axillary 
node clearance (ANC) in early breast cancer following the 
recent results of the AMAROS trial which demonstrated 
equivalent local control but reduced arm lymphoedema after 
AR. Consequently AR is permissible within the POSNOC trial 
(evaluating the role of axillary treatment in women with 
early stage breast cancer and one or two sentinel node 
macrometastases).  
We set out to quantify axillary radiotherapy in terms of field 
placement and dose in UK radiotherapy centres participating 
in POSNOC.  
Materials and Methods: Data was collected from dummy run 
cases submitted as part of the POSNOC radiotherapy quality 
assurance programme and reviewed using radiotherapy plan 
visualisation software (VODCA). Anatomical points relative to 
the axillary nodal boundaries identified by RTOG (Radiation 
Therapy Oncology Group) within the Breast Cancer Atlas for 
Radiation Therapy Planning were defined to evaluate axillary 
field placement and dose to the axillary nodes at depth.  
• Field placement was assessed measuring the 50% isodose 
relative to the superior (cricoid cartilage), lateral (medial 
border of latissimus dorsi) and medial (trachea-midpoint 
cranial of the base of clavicle caudal of thyroid) extent of the 
axillary nodal boundaries.  
• Dose to the axillary nodal levels at depth was assessed by 
measuring a point dose at the posterior aspect of the 
midpoint of the cranial-caudal and lateral-medial extent of 
each nodal level boundary. 
Results: Figure 1: 
 
 
 
Conclusions: The results suggest that treatment fields 
encompass the axillary nodal boundaries in the superior and 
lateral dimensions irrespective of planning approach. 
However, there is a potential compromise regarding the 
coverage of the medial nodal boundary, with some cases not 
encompassing the complete medial extent proximal to the 
trachea. Comparing volume with field based techniques 
suggests that coverage of the medial supraclavicular nodes is 
optimised when adopting a volumetric planning approach. 
The POSNOC radiotherapy guidelines recommend that ≥ 80% 
of the prescribed dose is achieved at mid-axilla and that the 
dose to the supraclavicular fossa nodes should be >90% of the 
prescribed dose. The point dose results suggest that each 
method of prescribing and/or beam arrangement for axillary 
nodal radiotherapy can achieve these dose levels, but in 
some cases level 1 nodes received less than 75% of the 
prescribed dose. The evaluation of anatomical reference 
points represents a simple method for evaluating axillary 
nodal coverage for centres not using a volumetric planning 
approach.  
POSNOC is funded by the National Institute for Health 
Research Health Technology Assessment (NIHR HTA) 
Programme-12/35/17. 
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Purpose/Objective: In our clinic breast cancer patients who 
receive locoregional treatment are positioned on a CQual 
breastboard (CIVCO, USA). This set-up leaves room for 
inaccuracies, especially in the area of the cervical vertebrae.  
The aim of this study is to determine whether fixation of the 
chin improves the stability of the supraclavicular lymph node 
area. 
Materials and Methods: 
 
 
Figure 1: chin fixation 
In April 2014 chin fixation was introduced in our department 
for patients that receive locoregional radiotherapy for breast 
cancer. This chin fixation is made using posicast 
thermoplastic mask material (Macromedics, the Netherlands) 
and is attached to the breastboard (figure 1). 
To evaluate the potential benefit of chin fixation, a 
comparison was made between two groups of patients 
positioned without/with chin fixation. The two groups 
contained the last 13 patients before introducing chin 
fixation and the first 13 patients with chin fixation. The 
group without chin fixation was given verbal instruction by 
RTTs to turn the chin 45 degrees to the contralateral side. 
For both patient groups IGRT is performed on daily basis or 
once a week, dependent of the IGRTprotocol, using Cone-
Beam CT (CBCT) imaging.  
Clinically the correction of the patient set-up was based on 
registration of the chest wall/sternum using a bone match 
algorithm in XVI. 80 CBCTs per group with an average of 6 
CBCTs per patient were used for this study.  
The number of CBCTs ranged between 3 and 11 per patient. 
The stability of the supraclavicular lymph node area is 
defined as the change of position with respect to the chest 
